Walleye Capital LLC Rhythm Pharmaceuticals, Inc. Transaction History

Walleye Capital LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 14, 2023	BUY	$16.32 - $21.15 $4.21 Million - $5.45 Million	257,772 Added 187.1%	395,541 $6.52 Million
Q1 2023 May 15, 2023	BUY	$16.88 - $34.24 $2.33 Million - $4.72 Million	137,769 New	137,769 $2.46 Million
Q3 2022 Nov 14, 2022	BUY	$4.3 - $30.85 $822,903 - $5.9 Million	191,373 New	191,373 $4.69 Million
Q4 2021 Mar 03, 2022	SELL	$8.62 - $13.9 $429,663 - $692,845	-49,845 Closed	0 $0
Q3 2021 Nov 15, 2021	BUY	$11.68 - $20.72 $582,189 - $1.03 Million	49,845 New	49,845 $651,000

192

67.3M

834K

78.6K

Ticker RYTM
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 55,720,000
Market Cap $3.13B
Description
Rhythm Pharmaceuticals, Inc., a commercial-stage biopharmaceutical company, focuses on the development and commercialization of therapeutics for the treatment of rare genetic diseases of obesity. The company's lead product candidate is IMCIVREE, a potent melanocortin-4 receptor for the treatment of pro-opiomelanocortin (POMC), proprotein convert...

Get notified when there are updates to the investment portfolio of Walleye Capital LLC, based on Form 13F filings with the SEC.

Stay updated on Walleye Capital LLC with notifications on news.